Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 25% ± 8% | |
pericyte | 10 studies | 25% ± 5% | |
oligodendrocyte precursor cell | 9 studies | 26% ± 11% | |
regulatory T cell | 7 studies | 21% ± 7% | |
astrocyte | 4 studies | 21% ± 4% | |
Mueller cell | 4 studies | 34% ± 9% | |
CD4-positive, alpha-beta T cell | 3 studies | 24% ± 3% | |
glomerular endothelial cell | 3 studies | 22% ± 4% | |
abnormal cell | 3 studies | 28% ± 1% | |
T follicular helper cell | 3 studies | 22% ± 6% | |
erythroblast | 3 studies | 27% ± 8% |
Insufficient scRNA-seq data for expression of TRIB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2700.40 | 2608 / 2642 | 100% | 118.17 | 702 / 705 |
skin | 98% | 2513.95 | 1773 / 1809 | 100% | 268.56 | 471 / 472 |
breast | 100% | 5755.24 | 459 / 459 | 94% | 48.53 | 1050 / 1118 |
lung | 100% | 5928.03 | 578 / 578 | 89% | 44.58 | 1031 / 1155 |
prostate | 100% | 5422.51 | 245 / 245 | 88% | 31.94 | 444 / 502 |
thymus | 100% | 4006.43 | 652 / 653 | 87% | 27.51 | 526 / 605 |
ovary | 100% | 13949.03 | 180 / 180 | 86% | 37.80 | 371 / 430 |
adrenal gland | 100% | 8380.61 | 258 / 258 | 84% | 44.86 | 194 / 230 |
uterus | 100% | 4954.81 | 170 / 170 | 84% | 46.20 | 387 / 459 |
esophagus | 98% | 2609.47 | 1422 / 1445 | 83% | 35.60 | 151 / 183 |
kidney | 100% | 6583.21 | 89 / 89 | 76% | 50.91 | 689 / 901 |
pancreas | 81% | 2159.12 | 266 / 328 | 94% | 50.77 | 168 / 178 |
bladder | 100% | 3785.24 | 21 / 21 | 65% | 33.36 | 330 / 504 |
stomach | 100% | 4380.82 | 359 / 359 | 62% | 23.63 | 178 / 286 |
intestine | 99% | 3566.87 | 955 / 966 | 54% | 18.88 | 285 / 527 |
liver | 92% | 1490.64 | 209 / 226 | 46% | 16.15 | 188 / 406 |
adipose | 100% | 5969.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 146.71 | 80 / 80 |
spleen | 100% | 11620.34 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 3835.79 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3852.30 | 1328 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 40.41 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 35.37 | 25 / 29 |
muscle | 79% | 1035.07 | 638 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 34% | 506.27 | 312 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0043405 | Biological process | regulation of MAP kinase activity |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0055106 | Molecular function | ubiquitin-protein transferase regulator activity |
GO_0031434 | Molecular function | mitogen-activated protein kinase kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | TRIB2 |
Protein name | Tribbles homolog 2 (TRB-2) Tribbles homolog 2 |
Synonyms | TRB2 |
Description | FUNCTION: Interacts with MAPK kinases and regulates activation of MAP kinases. Does not display kinase activity (By similarity). . FUNCTION: Interacts with MAPK kinases and regulates activation of MAP kinases. Does not display kinase activity. . FUNCTION: Interacts with MAPK kinases and regulates activation of MAP kinases. Does not display kinase activity. . |
Accessions | ENST00000155926.9 B5MCX4 Q92519 ENST00000381465.2 ENST00000405331.3 F8WA18 |